December 27, 2004 Biotech moved lower on Monday, with the Centient Biotech 200 losing almost 1%, dropping 34.97 to 3538.86. In general, stocks began the day higher, lost some ground during the middle of the session, and then fell into the close. We cover Cellergy Pharmaceuticals, which received a Not Approvable letter, Genitope’s capital raise, Hemispherx’s lawsuit against alleged stock manipulation, and stem cell activity’s influence on the stock price of StemCells and Aastrom.
